1. Home
  2. YSG vs STOK Comparison

YSG vs STOK Comparison

Compare YSG & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YSG
  • STOK
  • Stock Information
  • Founded
  • YSG 2016
  • STOK 2014
  • Country
  • YSG China
  • STOK United States
  • Employees
  • YSG N/A
  • STOK N/A
  • Industry
  • YSG Package Goods/Cosmetics
  • STOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • YSG Consumer Discretionary
  • STOK Health Care
  • Exchange
  • YSG Nasdaq
  • STOK Nasdaq
  • Market Cap
  • YSG 889.0M
  • STOK 997.9M
  • IPO Year
  • YSG 2020
  • STOK 2019
  • Fundamental
  • Price
  • YSG $9.12
  • STOK $18.42
  • Analyst Decision
  • YSG
  • STOK Strong Buy
  • Analyst Count
  • YSG 0
  • STOK 6
  • Target Price
  • YSG N/A
  • STOK $26.60
  • AVG Volume (30 Days)
  • YSG 525.3K
  • STOK 933.9K
  • Earning Date
  • YSG 08-21-2025
  • STOK 08-12-2025
  • Dividend Yield
  • YSG N/A
  • STOK N/A
  • EPS Growth
  • YSG N/A
  • STOK N/A
  • EPS
  • YSG N/A
  • STOK 0.91
  • Revenue
  • YSG $475,930,821.00
  • STOK $199,893,000.00
  • Revenue This Year
  • YSG $17.93
  • STOK $409.12
  • Revenue Next Year
  • YSG $12.79
  • STOK N/A
  • P/E Ratio
  • YSG N/A
  • STOK $20.05
  • Revenue Growth
  • YSG 0.90
  • STOK 1218.82
  • 52 Week Low
  • YSG $3.01
  • STOK $5.35
  • 52 Week High
  • YSG $11.57
  • STOK $18.45
  • Technical
  • Relative Strength Index (RSI)
  • YSG 56.51
  • STOK 83.33
  • Support Level
  • YSG $8.80
  • STOK $12.86
  • Resistance Level
  • YSG $9.99
  • STOK $17.61
  • Average True Range (ATR)
  • YSG 0.56
  • STOK 0.99
  • MACD
  • YSG 0.05
  • STOK 0.48
  • Stochastic Oscillator
  • YSG 68.18
  • STOK 96.13

About YSG Yatsen Holding Limited

Yatsen Holding Ltd is engaged in the retail business of beauty products, skincare items, and other cosmetic products. The group's principal operations are currently organized into three segments on a product category basis, namely Color Cosmetics Brands, Skincare Brands, and others. The company's majority of revenue is generated from sales of Color Cosmetics Brands.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: